A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The primary objective will be to compare the Eurofarma and Alenia formulations regarding
their impact on the pulmonary function of mild to moderate persistent asthma patients and the
secondary objective will be to compare the three study formulations regarding the clinical
control of the symptoms and the patients' compliance to the treatment.